Eloxx Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2020
Total Assets: $26.5M
Liabilities Breakdown FY2020
Total Liabilities: $16.2M
Asset Breakdown
Total Assets: $26.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $24.7M | 93.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $133.0K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.7M | 6.3% |
Liabilities Breakdown
Total Liabilities: $16.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $481.0K | 3.0% |
| Long-Term Debt | $6.4M | 39.2% |
| Other Liabilities | $9.4M | 57.8% |